• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

热带病蛋白激酶抑制的最新研究进展。

Recent results in protein kinase inhibition for tropical diseases.

机构信息

Department of Chemistry and Biochemistry, Montclair State University, 1 Normal Avenue, Montclair, NJ 07043, United States.

出版信息

Bioorg Med Chem Lett. 2012 Nov 15;22(22):6788-93. doi: 10.1016/j.bmcl.2012.09.044. Epub 2012 Sep 24.

DOI:10.1016/j.bmcl.2012.09.044
PMID:23063403
Abstract

Protein kinases are becoming widely investigated targets for treatment of protozoal parasitic tropical diseases such as malaria and leishmaniasis. The search for potent, selective inhibitors of these parasitic enzymes has been aided by the extensive variety of structures prepared for human diseases. Genomic approaches to target identification and validation have aided the search. Substantial progress has been made and research is continuing to expand in an effort to find safe, effective drug candidates for these difficult to treat and widespread diseases.

摘要

蛋白激酶正在成为治疗疟疾和利什曼病等热带寄生虫病的广泛研究目标。由于为人类疾病制备了大量的结构,这些寄生虫酶的有效、选择性抑制剂的寻找得到了帮助。基因组方法在目标鉴定和验证方面提供了帮助。已经取得了重大进展,并且正在继续努力寻找安全、有效的候选药物,以治疗这些难以治疗且广泛存在的疾病。

相似文献

1
Recent results in protein kinase inhibition for tropical diseases.热带病蛋白激酶抑制的最新研究进展。
Bioorg Med Chem Lett. 2012 Nov 15;22(22):6788-93. doi: 10.1016/j.bmcl.2012.09.044. Epub 2012 Sep 24.
2
Identification and characterization of novel small molecules as potent inhibitors of the plasmodial calcium-dependent protein kinase 1.新型小分子作为疟原虫钙依赖性蛋白激酶1的有效抑制剂的鉴定与表征
Biochemistry. 2009 Jul 14;48(27):6379-89. doi: 10.1021/bi9005122.
3
Malaria: targeting parasite and host cell kinomes.疟疾:靶向疟原虫和宿主细胞的激酶组
Biochim Biophys Acta. 2010 Mar;1804(3):604-12. doi: 10.1016/j.bbapap.2009.10.009. Epub 2009 Oct 17.
4
Substituted imidazopyridazines are potent and selective inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1).取代的咪唑并吡啶类化合物是恶性疟原虫钙依赖蛋白激酶 1(PfCDPK1)的有效和选择性抑制剂。
Bioorg Med Chem Lett. 2013 May 15;23(10):3064-9. doi: 10.1016/j.bmcl.2013.03.017. Epub 2013 Mar 21.
5
Are Carbonic Anhydrases Suitable Targets to Fight Protozoan Parasitic Diseases?碳酸酐酶是否适合作为抗原生动物寄生虫病的靶点?
Curr Med Chem. 2018;25(39):5266-5278. doi: 10.2174/0929867325666180326160121.
6
Targeting malaria protein kinases.靶向疟原虫蛋白激酶。
Adv Protein Chem Struct Biol. 2021;124:225-274. doi: 10.1016/bs.apcsb.2020.10.004. Epub 2020 Nov 1.
7
Stopping malaria parasites dead in their tracks.让疟原虫在其传播路径上彻底死亡。
Nat Chem Biol. 2008 Jun;4(6):334-5. doi: 10.1038/nchembio0608-334.
8
Targeting kinases in Plasmodium and Schistosoma: Same goals, different challenges.靶向疟原虫和血吸虫中的激酶:目标相同,挑战各异。
Biochim Biophys Acta. 2015 Oct;1854(10 Pt B):1637-43. doi: 10.1016/j.bbapap.2015.03.002. Epub 2015 Mar 12.
9
Selective inhibition of Pfmrk, a Plasmodium falciparum CDK, by antimalarial 1,3-diaryl-2-propenones.抗疟1,3 - 二芳基 - 2 - 丙烯酮对恶性疟原虫细胞周期蛋白依赖性激酶Pfmrk的选择性抑制作用
Bioorg Med Chem Lett. 2009 Apr 1;19(7):1982-5. doi: 10.1016/j.bmcl.2009.02.042. Epub 2009 Feb 13.
10
Drugging the Plasmodium kinome: the benefits of academia-industry synergy.靶向疟原虫激酶组:学术界与产业界协同合作的益处。
Trends Pharmacol Sci. 2008 May;29(5):241-9. doi: 10.1016/j.tips.2008.02.005. Epub 2008 Apr 18.

引用本文的文献

1
Construction of luciferase-expressing Neospora caninum and drug screening.构建表达荧光素酶的刚地弓形虫及药物筛选。
Parasit Vectors. 2024 Mar 8;17(1):118. doi: 10.1186/s13071-024-06195-8.
2
Protein kinases on carbon metabolism: potential targets for alternative chemotherapies against toxoplasmosis.碳代谢中的蛋白激酶:弓形虫病替代化疗的潜在靶点。
Front Cell Infect Microbiol. 2023 May 23;13:1175409. doi: 10.3389/fcimb.2023.1175409. eCollection 2023.
3
Malaria and tuberculosis as diseases of neglected populations: state of the art in chemotherapy and advances in the search for new drugs.
疟疾和结核病作为被忽视人群的疾病:化疗的最新进展和新药研究的进展。
Mem Inst Oswaldo Cruz. 2020 Oct 5;115:e200229. doi: 10.1590/0074-02760200229. eCollection 2020.
4
Nek8445, a protein kinase required for microtubule regulation and cytokinesis in .Nek8445,一种在. 中调节微管和胞质分裂所必需的蛋白激酶。
Mol Biol Cell. 2020 Jul 15;31(15):1611-1622. doi: 10.1091/mbc.E19-07-0406. Epub 2020 May 27.
5
Treatment with Bumped Kinase Inhibitor 1294 Is Safe and Leads to Significant Protection against Abortion and Vertical Transmission in Sheep Experimentally Infected with Toxoplasma gondii during Pregnancy.用 bumped 激酶抑制剂 1294 治疗在怀孕期间感染弓形虫的绵羊,安全且显著防止流产和垂直传播。
Antimicrob Agents Chemother. 2019 Jun 24;63(7). doi: 10.1128/AAC.02527-18. Print 2019 Jul.
6
Structure-activity relationships in a series of antiplasmodial thieno[2,3-b]pyridines.一系列抗疟噻吩并[2,3-b]吡啶的构效关系。
Malar J. 2019 Mar 21;18(1):89. doi: 10.1186/s12936-019-2725-y.
7
Emerging therapeutic targets for treatment of leishmaniasis.治疗利什曼病的新兴治疗靶点。
Expert Opin Ther Targets. 2018 Jun;22(6):467-486. doi: 10.1080/14728222.2018.1472241. Epub 2018 May 9.
8
Safety and efficacy of the bumped kinase inhibitor BKI-1553 in pregnant sheep experimentally infected with Neospora caninum tachyzoites.在感染 Neospora caninum 速殖子的实验孕羊中, bumped 激酶抑制剂 BKI-1553 的安全性和有效性。
Int J Parasitol Drugs Drug Resist. 2018 Apr;8(1):112-124. doi: 10.1016/j.ijpddr.2018.02.003. Epub 2018 Mar 2.
9
Two Novel Calcium-Dependent Protein Kinase 1 Inhibitors Interfere with Vertical Transmission in Mice Infected with Neospora caninum Tachyzoites.两种新型钙依赖性蛋白激酶1抑制剂干扰感染犬新孢子虫速殖子的小鼠的垂直传播。
Antimicrob Agents Chemother. 2017 Mar 24;61(4). doi: 10.1128/AAC.02324-16. Print 2017 Apr.
10
Drug target identification in protozoan parasites.原虫寄生虫中的药物靶点鉴定。
Expert Opin Drug Discov. 2016 Aug;11(8):815-24. doi: 10.1080/17460441.2016.1195945. Epub 2016 Jun 16.